| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/23/2006 | EP1691844A1 Methods and compositions for treatment of interferon-resistant tumors |
| 08/23/2006 | EP1691841A2 Compositions comprising two different populations of polymer-active agent conjugates |
| 08/23/2006 | EP1691829A1 Use of limk-1, its analogues and ligands for the production of a medicament against a thrombus formation or blood clotting disease |
| 08/23/2006 | EP1691827A1 Use of peptides derived from the alpha or beta chain of human fibronogen for the treatment of shock |
| 08/23/2006 | EP1691826A1 Excipients in drug delivery vehicles |
| 08/23/2006 | EP1691825A1 Stabilized interferon liquid formulations |
| 08/23/2006 | EP1691824A2 Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 08/23/2006 | EP1691823A2 Transdermal system for sustained delivery of polypeptides |
| 08/23/2006 | EP1691822A2 High-level expression of fusion polypeptides in plant seeds utilizing seed-storage proteins as fusion carriers |
| 08/23/2006 | EP1691820A2 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| 08/23/2006 | EP1691819A2 Chaperone-based therapy for niemann-pick disease |
| 08/23/2006 | EP1691818A2 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof |
| 08/23/2006 | EP1691799A2 Lipid rafts and clostridial toxins |
| 08/23/2006 | EP1691785A1 Excipients in drug delivery vehicles |
| 08/23/2006 | EP1691764A2 Methods for treating cancer using vascular endothelial cell growth inhibitor vegi-192a |
| 08/23/2006 | EP1691746A2 Mucoadhesive drug delivery devices and methods of making and using thereof |
| 08/23/2006 | EP1691744A2 Methods and reagents for the treatment of inflammatory disorders |
| 08/23/2006 | EP1691715A2 Surfactant-based gel as an injectable, sustained drug delivery vehicle |
| 08/23/2006 | EP1648923A4 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 08/23/2006 | EP1648922A4 Spatially-defined macrocyclic compounds useful for drug discovery |
| 08/23/2006 | EP1562634B1 Positional isomers of pegylated interferon alpha 2a |
| 08/23/2006 | EP1549747A4 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 08/23/2006 | EP1546184A4 Human immunosuppressive protein |
| 08/23/2006 | EP1515740B1 Aqueous preparation containing oligopeptides and etherified cyclodextrin |
| 08/23/2006 | EP1507794B1 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 08/23/2006 | EP1424892A4 Modulation of angiogenesis by a-beta peptides |
| 08/23/2006 | EP1402913B1 Dry powder inhalation system for transpulmonary administration, method of manufacturing a dry powdered preparation, and use of a freeze dried composition |
| 08/23/2006 | EP1363945B1 Modified derivatives of cck-8 |
| 08/23/2006 | EP1358318B1 Hybridoma cell line g250 and its use for producing monoclonal antibodies |
| 08/23/2006 | EP1339294B1 Nutritional composition for an immune condition |
| 08/23/2006 | EP1324762B1 Separation of cresol from mare's urine |
| 08/23/2006 | EP1292612B1 Glycopeptide phosphonate derivatives |
| 08/23/2006 | EP1240344B1 Replication incompetent herpes viruses for use in gene therapy |
| 08/23/2006 | EP1240337B1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 08/23/2006 | EP1171452B1 Pyrrolidincarbolylamino cyclic disulfides as vcam-vla4 antagonists |
| 08/23/2006 | EP1051482B1 Cytotoxic heteromeric protein combinatorial libraries |
| 08/23/2006 | EP1012181B1 Surface antigens and proteins useful in compositions for the diagnosis and prevention of lyme disease |
| 08/23/2006 | EP1007566B1 Therapeutic use of the smr1 protein and active derivatives thereof |
| 08/23/2006 | EP0998916B1 Medicinal compositions for application to mucosa |
| 08/23/2006 | EP0914827B1 Ophthalmic drug compositions |
| 08/23/2006 | EP0833636B1 Method for inhibiting neoplastic disease in mammals |
| 08/23/2006 | CN1823169A Process for manufacture of nematode-extracted anticoagulant protein (NAP) |
| 08/23/2006 | CN1823161A Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regenaration |
| 08/23/2006 | CN1823090A Platelet glycoprotein IB-alpha variant fusion polypeptides and methods of use thereof |
| 08/23/2006 | CN1823089A Method for producing a polypeptide |
| 08/23/2006 | CN1823088A Novel peptides that bind to the erythropoietin receptor |
| 08/23/2006 | CN1823087A Novel peptides that bind to the erythropoietin receptor |
| 08/23/2006 | CN1822854A Methods and compositions for controlling ectoparasites |
| 08/23/2006 | CN1822853A Cyclic analogs of human parathyroid hormone for the treatment of conditions characterized by hyperproliferative skin cells |
| 08/23/2006 | CN1822852A Recombinant human interferon-beta-1b polypeptides |
| 08/23/2006 | CN1822851A Stable analogs of peptide and polypeptide therapeutics |
| 08/23/2006 | CN1822850A Treatment or prevention of damage due to radiation exposure. |
| 08/23/2006 | CN1822849A Long acting biologically active conjugates |
| 08/23/2006 | CN1822846A Perivascular mesenchymal precursor cell induced blood vessel formation |
| 08/23/2006 | CN1822845A Means for preventing and treating cellular death and their biological applications |
| 08/23/2006 | CN1822824A Method of treating degenerative disc disease |
| 08/23/2006 | CN1822821A Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form |
| 08/23/2006 | CN1822817A Inhalable formulations for treating pulmonary hypertension and methods of using same |
| 08/23/2006 | CN1822765A Delivery of compounds with rehydrated blood cells |
| 08/23/2006 | CN1821411A Method for expressing hepatitis C virus envelope protein E2 by mammal cell with high efficient secretion |
| 08/23/2006 | CN1821397A Method for preparing recombinant goose interferon I and II |
| 08/23/2006 | CN1821271A Antibiotic peptide and its code sequence and use |
| 08/23/2006 | CN1821268A Goniothalamicim cyclopeptide B of anti-tumor compound and isomer and its preparing method |
| 08/23/2006 | CN1821267A Method for refining sik fibroin |
| 08/23/2006 | CN1820783A Thyroid hormone medicinal preparation |
| 08/23/2006 | CN1820782A Thyroid hormone medicinal preparation and its preparing method |
| 08/23/2006 | CN1820781A Use of compound PS-341 in preparing medicine for treating chronic granulocytic leukemia |
| 08/23/2006 | CN1820734A Treatment with anti-erbb2 antibodies |
| 08/23/2006 | CN1271205C Reconstituted human anti-HM1.24 antibody |
| 08/23/2006 | CN1271086C GLP-1 derivs. |
| 08/23/2006 | CN1270776C Ulcer quieting medicine its preparation and use |
| 08/23/2006 | CN1270775C Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enbancing agents |
| 08/23/2006 | CN1270774C Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 08/23/2006 | CN1270770C Polypeptide vaccine capable of effectively preventing pointed condyloma |
| 08/23/2006 | CN1270769C Cinobufotalin lyophilized powder for injection and its preparation method |
| 08/23/2006 | CN1270719C Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 08/23/2006 | CN1270621C Food-induced antisecretory proteins in egg yolk |
| 08/22/2006 | US7094946 Animal model for allergic disorders |
| 08/22/2006 | US7094909 Reacting an amide compound containing hydroxy and a carboxyl group and having benzene ring, with a halogenated alkyl aminocarbonyl-pyrrolidine with 2-fluoro groups substituted at the ring carbon, by amindation of amine and carboxyl group |
| 08/22/2006 | US7094887 UDP-N-acetylglucosamine: galactose-β1,3-N-acetylgalactosamine-α-R(GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase, C2GnT3 |
| 08/22/2006 | US7094884 A protein containing an amyloid beta (A beta ) peptide, a peptidyl prolyl isomerase chaperone,wherein the PrP and the peptidyl prolyl isomerase chaaperone are covalently linked, and such protein is soluble to at least 100 nM in a solution with a pH of 7.4 contains 20 nM sodium phosphate and 150 nM NaCl |
| 08/22/2006 | US7094882 Growth factor which acts through erb b-4 rtk |
| 08/22/2006 | US7094880 Decorin proteoglycan inhibitor of fibrinogen blood clotting |
| 08/22/2006 | US7094878 Aortic carboxypeptidase-like polypeptide |
| 08/22/2006 | US7094877 Protein for use in treatment of inflammation, nervous system, pain, arthritic and skin disorders |
| 08/22/2006 | US7094876 Human cDNAs and proteins and uses thereof |
| 08/22/2006 | US7094875 With advantages such as ability of the polypeptides to preferentially bind a CD28/CTLA-4 receptor at a level greater or less than the ability of human B7-1, inhibit altered level of T cell proliferation response greater than human B7-1 |
| 08/22/2006 | US7094874 Soluble CTLA4 mutant molecules |
| 08/22/2006 | US7094873 Polypeptide that interacts with heat shock proteins |
| 08/22/2006 | US7094869 Animal growth regulators |
| 08/22/2006 | US7094868 Peptides for recognition and targeting of GLIAL cell tumors |
| 08/22/2006 | US7094770 Treating hepatitus B, C and D; AIDS; antiproliferative agents |
| 08/22/2006 | US7094761 A GPCR-like protein for treating glaucoma |
| 08/22/2006 | US7094760 Peptides for treatment of inflammation and shock |
| 08/22/2006 | US7094759 peptide having a specific amino acid sequence suppresses initial adhesion of intraoral bacteria to teeth and periodontal tissue and prevents formation of a biofilm in an oral cavity. |
| 08/22/2006 | US7094758 Apoptotic compounds |
| 08/22/2006 | US7094756 relates to the surprising finding that overexpression of ABIN prevents TNF-induced lethal hepatitis in mice |
| 08/22/2006 | US7094755 Therapy and prophylaxis of cancer |
| 08/22/2006 | US7094754 Inhibitors of matrix metalloproteinases; chemoattractants for cell proliferation of fibroblasts and/or keratinocytes |
| 08/22/2006 | US7094753 Somatostatin analog and uses thereof |